The FDA’s complete response letter cited concerns that the Phase I/II IGNYTE (CT03767348) trial in advanced melanoma was not ...

Fingal County Council has declared a planning application by the National Transport Authority for a ‘strategic’ park-and-ride ...

TOPEKA, Kan. (WIBW) - Guidelines have been announced for free and reduced-price lunches for the 2025-26 academic year in ...

Martin Lewis has issued an urgent alert to anyone who had children during a 32-year span, warning they could be entitled to ...

The FDA has issued a complete response letter to Replimune indicating it is unable to approve the biologics license ...

A Republican's call to revoke New York mayoral candidate Zohran Mamdani's citizenship has raised fears about Donald Trump's ...

Dear Face Time, My under-eyes are getting crepe-y (I don’t know if that is a word?), and my products are settling into these ...

In 2022, the DWP discovered several State Pension cases where it seemed that historical periods of Home Responsibilities ...

Purple Biotech Ltd. ('Purple Biotech' or 'the Company') (NASDAQ/TASE: PPBT), a clinical-stage company developing ...

Replimune, which was seeking approval of RP1 in combination with Bristol Myers Squibb's Opdivo for the treatment of advanced melanoma, on Tuesday said the FDA issued a so-called complete response ...

Tourism and regular people-to-people exchanges had come to a halt during the COVID-19 pandemic. Simultaneously, bilateral ...

Shares fell 75% to $3.04, putting the stock on track for a record closing low, according to Dow Jones Market Data. The stock ...